You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dinutuximab

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed Neuroblastoma, Refractory Neuroblastoma Trial (Natural Killer Cells, Temozolomide, Irinotecan)

Recruiting
  • Relapsed Neuroblastoma
  • Refractory Neuroblastoma
  • Natural Killer Cells
  • +4 more
  • Columbus, Ohio
    Nationwide Children's Hospital
Oct 26, 2022

Neuroblastoma Trial in United States (131I-MIBG, Dinutuximab, Vorinostat)

Recruiting
  • Neuroblastoma
  • 131I-MIBG
  • +4 more
  • Los Angeles, California
  • +11 more
Jan 30, 2023

Ganglioneuroblastoma, High Risk Neuroblastoma Trial in Australia, New Zealand, United States (procedure, drug, biological,

Active, not recruiting
  • Ganglioneuroblastoma
  • High Risk Neuroblastoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +14 more
  • Los Angeles, California
  • +9 more
Sep 1, 2022

Relapsed Solid Tumor, Refractory Solid Tumor Trial in Worldwide (Abemaciclib, Irinotecan, Temozolomide)

Recruiting
  • Relapsed Solid Tumor
  • Refractory Solid Tumor
  • Phoenix, Arizona
  • +28 more
Dec 7, 2022

Ganglioneuroblastoma, Nodular, Neuroblastoma Trial in Worldwide (Dinutuximab, Irinotecan, Isotretinoin)

Active, not recruiting
  • Ganglioneuroblastoma, Nodular
  • Neuroblastoma
  • Dinutuximab
  • +4 more
  • Mesa, Arizona
  • +77 more
Aug 17, 2022

High Risk Neuroblastoma, Recurrent Neuroblastoma, Refractory Neuroblastoma Trial in Worldwide (Dinutuximab, Eflornithine

Recruiting
  • High Risk Neuroblastoma
  • +2 more
  • Dinutuximab
  • +4 more
  • Birmingham, Alabama
  • +141 more
Dec 28, 2022

Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma Trial in Worldwide

Active, not recruiting
Has Results
  • Localized Resectable Neuroblastoma
  • +5 more
  • Aldesleukin
  • +6 more
  • Birmingham, Alabama
  • +196 more
Dec 30, 2022

Small Cell Lung Cancer Trial in Worldwide (Dinutuximab, Irinotecan, Topotecan)

Completed
Has Results
  • Small Cell Lung Cancer
  • Dinutuximab
  • +2 more
  • Anchorage, Alaska
  • +225 more
Nov 12, 2020

High Risk Neuroblastoma Trial in United States (biological, other, drug)

Completed
Has Results
  • High Risk Neuroblastoma
  • Aldesleukin
  • +4 more
  • Loma Linda, California
  • +31 more
Jul 30, 2021

Ganglioneuroblastoma, Neuroblastoma Trial in Canada, Puerto Rico, United States (procedure, drug, biological, radiation)

Recruiting
  • Ganglioneuroblastoma
  • Neuroblastoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +18 more
  • Birmingham, Alabama
  • +158 more
Sep 14, 2022

Immunogenicity and Safety of Unituxin® in High-Risk

Terminated
Has Results
  • Neuroblastoma
  • Dinutuximab
  • Birmingham, Alabama
  • +17 more
Jun 11, 2019